What's new at Xpedite Diagnostics?

A British-Brazilian research group published the first peer-reviewed paper about their work utilizing a SwiftX extraction kit by Xpedite Diagnostics.

Xpedite Diagnostics presented a round-up on nucleic acid extraction with all its aspects and a detailed view on fast nucleic acid extraction for point-of-care applications.

Xpedite Diagnostics received the grant notice of the Bavarian State Ministry for a proposal on an project on applied molecular diagnostics research.

Our old website was replaced by a modern and high performing website based on the TYPO3 content management system.

QMS and products of Xpedite Diagnostics have been updated to ensure full IVDR compliance. CE-IVD kits for rapid extraction of RNA and DNA, SwiftX Swabs and SwiftX Media, now Class A products under IVDR.

We have launched a new kit for rapid DNA isolation from liquid specimens such as oral fluid and urine. SwiftX™ Hi-Sense includes a cell and virus capture step and our proprietary Reverse Purification technology.

We attended the ECCMID 2022 in Lisbon, one the world's largest congresses in the area of Infectious Diseases. Read how it turned out to be a successful event for Xpedite Diagnostics...

We started to host webinars for the scientific community! By that, we aim to intensify our interaction with scientists working in Molecular Diagnostics. The first webinar was focussing on "Point-of-Care Nucleic Acid Extraction" and was conducted in January. All sessions have been…

Our mission and business was recognized as an innovative project and has been granted €100K funding from Bavarian Funding Bank.

Our third product, SwiftX™ Media, has just been launched and is now available as research product as well as for use in routine in-vitro-diagnostic procedures.